Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
27,51 USD | -0,94% | -5,46% | -4,94% |
23/05 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call | |
08/05 | Transcript : Supernus Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Omzet 2024 * | 600 mln. 553 mln. | Omzet 2025 * | 625 mln. 575 mln. | Marktkapitalisatie | 1,51 mld. 1,39 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 14 mln. 12,89 mln. | Nettowinst (verlies) 2025 * | -41 mln. -37,75 mln. | EV/omzet 2024 * | 2,52 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,42 x |
K/w-verhouding 2024 * |
110
x | K/w-verhouding 2025 * |
-37,2
x | Werknemers | 652 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,98% |
Recentste transcriptie over Supernus Pharmaceuticals, Inc.
1 dag | -0,94% | ||
1 week | -5,46% | ||
Lopende maand | -8,60% | ||
1 maand | -8,51% | ||
3 maanden | -6,75% | ||
6 maanden | -1,15% | ||
Lopend jaar | -4,94% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Khattar
FOU | Founder | 62 | 30-03-05 |
Timothy Dec
DFI | Director of Finance/CFO | 66 | 23-08-21 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-01-05 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 64 | 23-03-15 |
Charles Newhall
CHM | Chairman | 79 | 30-03-05 |
John Siebert
BRD | Director/Board Member | 84 | 01-01-11 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.94% | 28 M€ | -1,64% | ||
0.94% | 14 M€ | -4,76% | ||
0.38% | 25 M€ | -2,72% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-05-24 | 27,51 | -0,94% | 453 220 |
23-05-24 | 27,77 | -0,36% | 623 542 |
22-05-24 | 27,87 | -0,64% | 966 793 |
21-05-24 | 28,05 | -2,50% | 706 784 |
uitgestelde koers Nasdaq, 24 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,94% | 1,51 mld. | |
+16,17% | 79,16 mld. | |
+8,99% | 8,72 mld. | |
-16,43% | 4,79 mld. | |
+48,34% | 4,62 mld. | |
+2,91% | 3,82 mld. | |
+14,51% | 2,33 mld. | |
-26,94% | 2,2 mld. | |
+16,55% | 2,1 mld. | |
-36,25% | 2,04 mld. |